|
November 15 (Fri) 08:00-09:30 |
Concurrent Symposium 1 (Kidney/Pancreas)
ENG
New Technology in Transplantation |
Room 3F-1 | |
|---|---|---|---|
| Chair(s) |
Jamil R. Azzi (Harvard Medical School, USA) Jae Berm Park (Samsung Medical Center, Korea) |
||
| 08:00-08:20 |
AI in Medical Field
Jong Chul Ye (KAIST, Korea) |
CV Lecture Note | |
| 08:20-08:40 |
AI in Kidney Pathology
Heounjeong Go (Asan Medical Center, Korea) |
CV Lecture Note | |
| 08:40-09:00 |
Microbiome in Kidney Transplantation
Kwang Hyun Cha (KIST, Korea) |
CV Lecture Note | |
| 09:00-09:20 |
Tissue Engineering and Regeneration
Ryuichi Nishinakamura (Kumamoto University, Japan) |
CV Lecture Note | |
| 09:20-09:30 | Discussion | ||
|
November 15 (Fri) 08:00-09:30 |
Concurrent Symposium 2 (Liver)
ENG
Various Researches and Technologies to Future Direction in Liver Transplantation |
Room 5F-1 | |
|---|---|---|---|
| Chair(s) |
Dongho Choi (Hanyang University, Korea) Andrea Schlegel (Clevland Clinic, USA) |
||
| 08:00-08:30 |
Recellularized Pig Liver With Human Cells
Scott Nyberg (Mayo Clinic, USA) |
CV Lecture Note | |
| 08:30-09:00 |
3D Bioprinting Strategies for Recapitulation of Hepatic Structure and Function in Bioengineered Liver
Yohan Kim (Sungkyunkwan University, Korea) |
CV Lecture Note | |
| 09:00-09:30 |
Augmented Reality Application in Liver Surgery
Gao Yujia (National University Hospital, Singapore) |
CV Lecture Note | |
|
November 15 (Fri) 08:00-09:30 |
Concurrent Symposium 3 (Basic)
ENG
Immunoregulatory Cells in Organ Transplantation |
Room 5F-2 | |
|---|---|---|---|
| Chair(s) |
Tae Jin Kim (Sungkyunkwan University, Korea) Defu Zeng (City of Hope National Medical Center, USA) |
||
| 08:00-08:30 |
PD-L1 Augmentation of in Vivo Generation of pTreg Cells
Defu Zeng (City of Hope National Medical Center, USA) |
Lecture Note | |
| 08:30-09:00 |
IL-2 Receptor Engineering and Treg Cells
Toshihito Hirai (Tokyo Women's Medical University, Japan) |
CV Lecture Note | |
| 09:00-09:30 |
Treg Subpopulations in Organ Transplantation
Eui-Cheol Shin (KAIST, Korea) |
CV Lecture Note | |
|
November 15 (Fri) 08:00-09:30 |
장기등의 기증 및 이식에 관한 종합계획('25-'29)
KOR
|
Room 6F-2 | |
|---|---|---|---|
| 08:00-08:10 |
정책과제 필요성 및 추진내역 총괄보고
김명수(세브란스병원) |
||
| 08:10-08:20 |
제1분과: 생명나눔 문화확산 및 기증자 예우
노한(가천의대 신장내과) |
||
| 08:20-08:30 |
제2분과: 뇌사기증 확대
안형준(경희의대 외과) |
||
| 08:30-08:40 |
제3분과: 생존기증 관리체계
강은정(서울의대 신장내과) |
||
| 08:40-08:50 |
제4분과: 새로운 장기기증 발굴
김동식(고려의대 외과) |
||
| 08:50-09:30 | 참석자 질의응답 및 패널 토의 | ||
|
November 15 (Fri) 10:00-10:30 |
Special Lecture 2
ENG
|
Room 3F-1 | |
|---|---|---|---|
| Chair(s) | Jae Won Joh (Sungkyunkwan University, Korea) | ||
| 10:00-10:30 |
Development of Transplantable Liver from Chimeric Pig
Scott Nyberg (Mayo Clinic, USA) |
CV Lecture Note | |
|
November 15 (Fri) 10:30-11:00 |
Keynote Lecture 1
ENG
|
Room 3F-1 | |
|---|---|---|---|
| Chair(s) | Seok Min Kang (Yonsei University, Korea) | ||
| 10:30-11:00 |
DCD Heart Transplantation
Andreas Zuckermann (Medical University of Vienna, Austria) |
||
|
November 15 (Fri) 11:00-12:00 |
Plenary Session 1 (Best Papers)
ENG
|
Room 3F-1 | |
|---|---|---|---|
| Chair(s) |
Dong Jin Joo (Yonsei University, Korea) Byung Ha Chung (The Catholic University of Korea, Korea) |
||
| 11:00-11:15 |
Glomerular Transcriptomic Analysis of Recurrent IgA Nephropathy After Kidney Transplantation Reveals the Involvement of B-Cell Immune Response
Jae-Ik Oh (Seoul National University College of Medicine, Korea) |
Abstract | |
| 11:15-11:30 |
3D-Printed Omentum Patch Transplantation Reduces Kidney Fibrosis After Acute Kidney Injury
Wencheng Jin (Seoul National University Boramae Medical Center, China) |
Abstract | |
| 11:30-11:45 |
QUALITY Score : Development of Integrative Prognostic Index for Living Donor Liver Using Multicentric Registry Data
Deok-Gie Kim (Severance Hospital, Korea) |
Abstract | |
| 11:45-12:00 |
Whole Slide Image-Based Deep Learning Method to Predict EAD in Liver Transplantation
Liaoran Wang (Zhejiang University, China) |
Abstract | |
|
November 15 (Fri) 12:00-12:30 |
Living Legend Session
ENG
The Road Never Taken: a Surgeon's Journey |
Room 3F-1 | |
|---|---|---|---|
| Chair(s) | Oh Jung Kwon (Hanyang University, Korea) | ||
| 12:00-12:05 |
Introduction of Prof. Jin Young Kwak
Dongho Choi (Hanyang University, Korea) |
||
| 12:05-12:15 | The Road Never Taken: a Surgeon's Journey (movie) | ||
| 12:15-12:20 | Award Ceremony | ||
| 12:20-12:30 |
Acceptance Speech
Jin Young Kwak (Hanyang University, Korea) |
||
|
November 15 (Fri) 12:30-13:00 |
General Assembly
|
Room 6F-1 | |
|---|---|---|---|
|
November 15 (Fri) 12:40-13:40 |
Luncheon Symposium 2 (Astellas Pharma Korea)
ENG
Post-Transplant Complications Management |
Room 3F-1 | |
|---|---|---|---|
| Chair(s) |
Sun Cheol Park (The Catholic University of Korea, Korea) Gi-Won Song (Asan Medical Center, Korea) |
||
| 12:45-13:10 |
Risk Prediction of BK Viremia After Kidney Transplantation and the Impact of Immunosuppressant Strategies: Findings from the EMR Study Using Machine Learning
Hyunwook Kwon (Asan Medical Center, Korea) |
||
| 13:10-13:35 |
Strategies of the Management of Hepatorenal Syndrome and the Use of the CNI for Long-Term Survival of Recipient
Jae Geun Lee (Yonsei University, Korea) |
||
|
November 15 (Fri) 13:40-14:40 |
Oral Presentation 1 (Kidney/Pancreas)
ENG
|
Room 3F-1 | |
|---|---|---|---|
| Chair(s) |
Cheol Woong Jung (Korea University, Korea) Chan Duck Kim (Kyungpook National University, Korea) |
||
| 13:40-13:50 |
Diagnostic Yield of Kidney Disease Gene Panel Testing During Kidney Transplant Evaluation
Hanbi Lee (The Catholic University of Korea Seoul St. Mary's Hospital , Korea) |
Abstract | |
| 13:50-14:00 |
Protocolised Pre-Transplant Abdominal CT Screening Is Useful in Evaluation of High-Risk Kidney Transplant Waitlist Candidates
Sharel Zi Hui Ong (Singapore General Hospital , Singapore) |
Abstract | |
| 14:00-14:10 |
Prevalence and Risk Factors of Frailty in Long-Term Kidney Transplant Recipients: A Prospective Study
Young Jin Yoo (Yonsei University College of Medicine, Korea) |
Abstract | |
| 14:10-14:20 |
Optimization of a Model for Predicting Renal Function After Living Kidney Transplantation Using CT Volumetry
Yu Kijima (Tokyo Women's Medical University, Japan) |
Abstract | |
| 14:20-14:30 |
A Comparative Analysis of Kidney Transplantation Outcomes in Systemic Lupus Erythematosus Patients With Disease Flare Vs. Non-Flare Groups
Jin-Myung Kim (Asan Medical Center, Korea) |
Abstract | |
| 14:30-14:40 |
Survival Benefit of HLA-Incompatible Living Donor Kidney Transplantation Compared to Waiting Deceased Donor Kidney Transplantation in Elderly Patients
Hwa-Hee Koh (Severance Hospital, Korea) |
Abstract | |
|
November 15 (Fri) 13:40-14:40 |
Oral Presentation 2 (Liver)
ENG
|
Room 5F-1 | |
|---|---|---|---|
| Chair(s) |
Dong Jin Joo (Yonsei University, Korea) Tae-Seok Kim (Keimyung University, Korea) |
||
| 13:40-13:50 |
Survival Benefits in Living-Donor Liver Transplantation: a Nested Case-Control Analysis Based on the MELD Score Trajectories from the Waitlist.
Seung Hyuk Yim (Yonsei University College of Medicine, Korea) |
Abstract | |
| 13:50-14:00 |
Recipient and Donor SIRPa Genotypic Variant Combination Modulates Immune Response After Living Donor Liver Transplantation
Akhmet Seidakhmetov (Hiroshima University, Japan) |
Abstract | |
| 14:00-14:10 |
Predicting Futile Outcomes Following Deceased Donor Liver Transplantation in Patients With MELD-Na Score Above 30: A Retrospective International Multicenter Cohort Study
Hye-Sung Jo (Korea University Anam Hospita, Korea) |
Abstract | |
| 14:10-14:20 |
Impact of New Portal Reconstruction Strategy on Portal Vein Growth and Outcomes in Living-Donor Liver Transplantation for Small Children With Biliary Atresia
Hikaru Aoki (Kyoto University, Japan) |
Abstract | |
| 14:20-14:30 |
The Role of FOXO1 in Post-Transplant Recurrence of Hepatocellular Carcinoma: A Study on Diagnostic and Therapeutic Targets
Chao Wang (zhejiang university, China) |
Abstract | |
|
November 15 (Fri) 13:40-14:40 |
Xenotransplantation Symposium 1
ENG
How to Launch Clinical Trials of Xenotransplantation in Asia |
Room 6F-1 | |
|---|---|---|---|
| Chair(s) |
Hyun-il Kim (Optipharm, Korea) Hara Hidetaka (The Transplantation Institute of the Second Affiliated Hospital, China) |
||
| 13:40-13:55 |
Cultivation of DPF Gene-Edited Donor Pigs and Exploratory Subclinical Research
Dengke Pan (Chengdu Clonorgan Biotechnology Co., China) |
CV Lecture Note | |
| 13:55-14:10 |
Fetal Kidney Grafts from Pigs in Japan: A DPF Protocol of Production and Long-Term Cryopreservation
Eiji Kobayashi (Jikei University, Japan) |
CV Lecture Note | |
| 14:10-14:25 |
Approaches to the Clinical Xenotransplantation in Korea
Ik Jin Yun (Konkuk University, Korea) |
CV Lecture Note | |
| 14:25-14:40 |
Panel Discussion
Namhyung Kim (Wuyi University, China) , Shuji Miyagawa (Osaka University, Japan) |
||
|
November 15 (Fri) 13:40-14:40 |
KOTRY Joint Symposium
ENG
Heart Failure, Transplantation, and Mechanical Circulatory Support |
Room 6F-2 | |
|---|---|---|---|
| Chair(s) |
Hae-Young Lee (Seoul National University, Korea) Myoung Soo Kim (Yonsei University, Korea) |
||
| 13:40-14:10 |
Collaboration With KoTry Registry With International Society of Heart-Lung Transplantation Registry
Rebecca Cogswell (University of Minnesota, USA) |
||
| 14:10-14:40 |
Importance of National Registry for Heart Transplantation and Mechanical Circulatory Support
Yang Hyun Cho (Sungkyunkwan University, Korea) |
||
|
November 15 (Fri) 13:40-14:40 |
Woman In Transplantation (WIT) in KST
ENG
|
Room 5F-3 | |
|---|---|---|---|
| Chair(s) |
Yeong Hoon Kim (Inje University, Korea) Khin Thida Thwin (ARYU Hospital, Myanmar) |
||
| 13:40-14:10 |
Achieving Gender Equality in Medicine
Jong Mi Kim (Coventry University, UK) |
||
| 14:10-14:30 |
Career Development in Medical Field
Rose Marie Liquete (National Kidney and Transplant Institute, Philippines) |
CV Lecture Note | |
|
November 15 (Fri) 14:40-15:10 |
Mini-oral Presentation 1 (Liver)
ENG
|
Room 6F-3 | |
|---|---|---|---|
| Chair(s) | Seok-Hwan Kim (Chungnam National University, Korea) | ||
| 14:40-14:45 |
Identifying Risk Factors for Diffuse Intrahepatic Biliary Stricture in ABO-Incompatible Living Donor Liver Transplantation: an Analysis of 1,000 Cases.
Young-In Yoon (Asan Medical Center, Korea) |
Abstract | |
| 14:45-14:50 |
Optimizing Thrombophilia Screening Algorithms for Living Liver Donors: Prevalence and Decision-Making Insights in Korean Candidates
Sola Lee (Chonnam National University Hospital, Korea) |
Abstract | |
| 14:50-14:55 |
Incidence of Epstein-Barr Virus and Risk of Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: A Single-Center Study in Korea (2019-2024)
Kyong Ihn (Yonsei University College of Medicine, Korea) |
Abstract | |
| 14:55-15:00 |
Prognostic Impact of Macrotrabecular-Massive Hepatocellular Carcinoma in Liver Transplantation Surpassing Current Selection Criteria: A Retrospective Cohort Study
Eun-Ki Min (Severance Hospital, Korea) |
Abstract | |
| 15:00-15:05 |
Breakthrough Invasive Fungal Infection in Liver Transplantation
Chih Yao Hu (Taipei Veterans General Hospital, Taiwan) |
Abstract | |
| 15:05:15:10 |
Optimizing Liver Ex Vivo Splitting With Indocyanine Green: A Fluorescence-Guided Methodology
Sang Hyuk Park (Seoul National University Hospital, Korea) |
Abstract | |
|
November 15 (Fri) 14:40-15:10 |
Mini-oral Presentation 2 (Liver)
ENG
|
Room 6F-3 | |
|---|---|---|---|
| Chair(s) | Youngmok Park (Pusan National University, Korea) | ||
| 14:40-14:45 |
Outcomes and Risk Factors for De Novo Major Depressive Disorder After Liver Transplantation: Nested Case Control Study
Young Jin Yoo (Yonsei University College of Medicine, Korea) |
Abstract | |
| 14:45-14:50 |
CYP3A5 Single Nucleotide Polymorphism Affects Tacrolimus Intrapatient Variability After Liver Transplantation
Saran Ochir Gongor (Seoul National University College of Medicine, Korea) |
Abstract | |
| 14:50-14:55 |
Unique Multidisciplinary Approach in Living Donor Liver Transplantation to Achieve Total Physiological Revascularization in a Patient With Complete Occlusion of Portal Vein System With Combined Chronic and Sub-Acute Thrombosis
Jaeyoon Kim (Seoul National University Hospital, Korea) |
Abstract | |
| 14:55-15:00 |
Evaluating the SALT Prediction Model (Survival After Liver Transplantation for Hepatocellular Carcinoma): an External Validation Study for 5 Years
Min Kyoung Kim (Seoul National University Hospital, Korea) |
Abstract | |
| 15:00-15:05 |
Outcome of Living Donor Liver Transplant in Donors With Body Mass Index 30
Kumaraswamy Parthasarathy (Consultant, Asian institute of gastroenterology hospital, Hyderabad, India) |
Abstract | |
| 15:05:15:10 |
Anatomical Risk Factors for Portal Vein Complications Following Right Hepatectomy in Living Donors
Young-In Yoon (Asan Medical Center, Korea) |
Abstract | |
|
November 15 (Fri) 14:40-15:10 |
Mini-oral Presentation 3 (Kidney/Pancreas)
ENG
|
Room 6F-4 | |
|---|---|---|---|
| Chair(s) | Eun Jeong Kang (Seoul National University, Korea) | ||
| 14:40-14:45 |
Urinary Cysteine Levels Post-Transplant: A Potential Biomarker for Acute T-Cell Mediated Rejection in Renal Transplantation
Suyong Lee (Seoul National University Hospital, Korea) |
Abstract | |
| 14:45-14:50 |
Living Donor Kidney Transplantation Referral Outcomes at One Year Experience from Singapore General Hospital
Li Ting Siew (Singapore General Hospital, Singapore) |
Abstract | |
| 14:50-14:55 |
Long-Term Infectious Disease and Risk Factors in Korean Kidney Transplant Patients: Results from the KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) Study
Junghwa Ryu (Ewha Womans University Medical Center, Korea) |
Abstract | |
| 14:55-15:00 |
Post-Transplantation Dynamics of Non-HLA Antibodies and Early Antibody Intensity as Predictors of ABMR in Kidney Transplantation
Xiantian Pan (The First Affiliated Hospital of Sun Yat-sen University, China) |
Abstract | |
| 15:00-15:05 |
A Prediction Scheme for eGFR of Deceased Donor Renal Transplant Recipient in Korean by Machine Learning
Joon Seok Oh (BongSeng Memorial Hospital, Korea) |
Abstract | |
| 15:05:15:10 |
Graft Outcomes of ABOi-KTs Are Superior to Those of ABOc-KTs Over a Follow-up of 15 Years: Single Center Experiences
Dong Ryeol Lee (Maryknoll General Hospital, Korea) |
Abstract | |
|
November 15 (Fri) 14:40-15:10 |
Mini-oral Presentation 4 (Kidney/Pancreas)
ENG
|
Room 6F-4 | |
|---|---|---|---|
| Chair(s) | Hanbi Lee (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) | ||
| 14:40-14:45 |
Use of Electrothermal Device (Ligasure) for Iliac Vessel Dissection in Kidney Transplantation at National Kidney and Transplant Institute: an Initial Experience
Datu Nasser Pendatun III (Transplant Surgery Fellow, Philippines) |
Abstract | |
| 14:45-14:50 |
Clinical Outcomes of ABO Incompatible Kidney Transplantation With Delayed-Initiation Immunosuppression Protocol
Ji Eun Kim (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
| 14:50-14:55 |
The Prognostic Factor of Gender Mismatch With Acute Rejection of Living Donor Kidney Transplant Recipients in Indonesia: A 10-Year Retrospective Study
Dimas Septiar (Dr. Cipto Mangunkusumo General Hospital, Indonesia) |
Abstract | |
| 14:55-15:00 |
Outcome of Kidney Transplantation from Deceased Organ Donors With Proteinuria
Victor Guerrero (National Kidney and Transplant Institute, Philippines) |
Abstract | |
| 15:00-15:05 |
Reducing Pediatric Kidney Transplant Rejection Rates: A Quality Improvement Initiative
Razgah Aldhafiry (King Faisal Specialist Hospital-Riyadh, Saudi Arabia) |
Abstract | |
| 15:05:15:10 |
Sex Differences in the Risk of Bladder Cancer Among Kidney Transplant Recipients and Patients With Kidney Failure Receiving Hemodialysis: a Nationwide Cohort Study
Chan-Young Jung (Asan Medical Center, Korea) |
Abstract | |
|
November 15 (Fri) 14:40-15:10 |
Mini-oral Presentation 6 (Xenotransplantation)
ENG
|
Room 6F-5 | |
|---|---|---|---|
| Chair(s) | Jae Young Kim (Gachon University, Korea) | ||
| 14:40-14:45 |
Conditions and Research Status for Primate Non-Clinical Trials to Initiate Clinical Trials for Partial Thickness Corneal in Korea
Ki Cheul Shin (Konkuk University Medical Center, Korea) |
Abstract | |
| 14:45-14:50 |
Comparion of the Opportunities and Challenges of Heart Xenotransplantation Between US and China
Amy Fengjue Zhou (School of Medicine, Georgetown University , USA |
Abstract | |
| 14:50-14:55 |
Report of Gene-Edited Pig-Rhesus Monkey Heterotopic Heart Xenotransplantation Experiment
Zhipeng Ren (China) |
Abstract | |
| 14:55-15:00 |
The First More Than 6 Months Survival of Pig to Monkey Xeno Heart Transplantation in Korea
Ik Jin Yun (Konkuk University Medical Center, Korea) |
Abstract | |
| 15:00-15:05 |
The Impact of COVID-19 Vaccination and Infection on Anti-Triple-Knockout Pig Antibodies in End-Stage Liver Disease Patients
Liaoran Wang (Zhejiang University, China) |
Abstract | |
|
November 15 (Fri) 15:10-16:40 |
Concurrent Symposium 4 (Liver)
ENG
Pediatric Transplantation |
Room 5F-1 | |
|---|---|---|---|
| Chair(s) |
Sanghoon Lee (Sungkyunkwan University, Korea) Kyung Mo Kim (Asan Medical Center, Korea) |
||
| 15:10-15:30 |
Technical Considerations in Liver Transplantation for Infants and Small Children: North American Perspective
George Mazariegos (University of Pittsburgh, USA) |
CV Lecture Note | |
| 15:30-15:50 |
Technical Considerations in Liver Transplantation for Infants and Small Children: Asian Perspective
Mureo Kasahara (National Center for Child Health and Development (NCCHD), Japan) |
CV Lecture Note | |
| 15:50-16:10 |
3D Printing Technology to Predict Size-matching in Liver Transplantation
Jinsoo Rhu (Samsung Medical Center, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
Infectious Considerations in Young Transplant Recipients
Ji-Man Kang (Yonsei University, Korea) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 15 (Fri) 15:10-16:40 |
Concurrent Symposium 5 (Kidney/Pancreas)
ENG
Care of Post Transplant Malignancy |
Room 6F-1 | |
|---|---|---|---|
| Chair(s) |
Jaeseok Yang (Yonsei University, Korea) Yi-Ming Shyr (Taipei Veterans General Hospital, Taiwan) |
||
| 15:10-15:30 |
Prevention and Management of Post-Transplant Malignancy
Kajohnsak Noppakun (Chiang Mai University, Thailand) |
CV Lecture Note | |
| 15:30-15:50 |
Immune Checkpoint Inhibitor in Solid Organ Transplant
Myung Gyu Kim (Korea University, Korea) |
CV Lecture Note | |
| 15:50-16:10 |
CAR-T Therapy for Kidney Transplant Recipients- Nephrologist’s View
Naoka Murakami (Harvard Medical School, USA) |
CV Lecture Note | |
| 16:10-16:30 |
Virus Specific & CAR-T Cells for PTLD After Solid Organ Transplants
Rubinstein Jeremy (University of Cincinnati, USA) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 15 (Fri) 15:10-16:40 |
Concurrent Symposium 6 (Basic)
ENG
Recent Update on Immunology of Organ Transplantation |
Room 5F-2 | |
|---|---|---|---|
| Chair(s) |
Eui-Cheol Shin (KAIST, Korea) Toshihito Hirai (Tokyo Women's Medical University, Japan) |
||
| 15:10-15:40 |
IL-2 Signals and Foxp3-Rich Lymphoid Structures in Allograft
Yoshito Yamada (Kyoto University Graduate School of Medicine, Japan) |
CV Lecture Note | |
| 15:40-16:10 |
Gamma-Delata T Cells & Organ Transplantation
Tae Jin Kim (Sungkyunkwan University, Korea) |
CV Lecture Note | |
| 16:10-16:40 |
Immunology of Xenotransplantation
Hyun Je Kim (Seoul National University, Korea) |
CV Lecture Note | |
|
November 15 (Fri) 15:10-16:40 |
Concurrent Symposium 7 (Infection)
ENG
Antibiotic Stewardship in Transplant Setting |
Room 6F-2 | |
|---|---|---|---|
| Chair(s) |
Sang Il Kim (The Catholic University of Korea, Korea) Myoung Soo Kim (Yonsei University, Korea) |
||
| 15:10-15:30 |
What Is Antibiotic Stewardship?: ID Physician's View
Tan Ban Hock (Duke-NUS Medical School, Singapore) |
CV Lecture Note | |
| 15:30-15:50 |
Antibiotic Stewardship: What Transplant Surgeons Want
Hyung Joon Ahn (Kyung Hee University, Korea) |
CV Lecture Note | |
| 15:50-16:10 |
Antibiotic Stewardship: Pharmacist's Role
Eunjeong Heo (Seoul National University, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
Antibiotic Stewardship: Laboratory's Role
Ki Ho Hong (Yonsei University, Korea) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 15 (Fri) 15:10-16:40 |
Concurrent Symposium 8 (Lung)
ENG
Consideration of High-Risk Candidate |
Room 5F-3 | |
|---|---|---|---|
| Chair(s) |
Moo Suk Park (Yonsei University, Korea) Masaaki Sato (The University of Tokyo, Japan) |
||
| 15:10-15:30 |
How to Evaluate Frailty
Erika D Lease (University of Washington, USA) |
||
| 15:30-15:50 |
How to Manage Elderly Patient
Ala Woo (Yonsei University, Korea) |
||
| 15:50-16:10 |
Effect of Lung Transplant of Malnutrition (Low BMI) Recipient
Hye Ju Yeo (Pusan National University, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
How to Overcome Short Stature Candidate
Daisuke Nakajima (Kyoto University, Japan) |
CV Lecture Note | |
| 16:30-16:40 |
Panel Discussion
Sunghoon Park (Hallym University, Korea) , Jieun Park (Ajou University, Korea) , Junghee Lee (Sungkyunkwan University, Korea) |
||
|
November 15 (Fri) 16:40-17:40 |
Oral Presentation 3 (Liver)
ENG
|
Room 5F-1 | |
|---|---|---|---|
| Chair(s) |
Bong-Wan Kim (Ajou University, Korea) Geun Hong (Ewha Womans University, Korea) |
||
| 16:40-16:50 |
Outcomes and Key Determinants in Living Donor Liver Transplants from Elderly Donors: A Multicenter Cohort Analyses
Eun-Ki Min (Severance Hospital, Korea) |
Abstract | |
| 16:50-17:00 |
Clinical Usefulness of Digital Single-Operator Cholangioscopy for Post-Liver Transplant Anastomotic Stricture: SPYPASS-2 Study
Woo Hyun Paik (Seoul National University Hospital, Korea) |
Abstract | |
| 17:00-17:10 |
Perioperative Subcutaneous Adipose Tissue Radiodensity Impacts Outcomes of Liver Transplantation for Hepatocellular Carcinoma: A Multicenter Retrospective Study
Zhihang Hu (Zhejiang University School of Medicine, China) |
Abstract | |
| 17:10-17:20 |
Immune Checkpoint Inhibitor - Risk Factors for Rejection After Liver Transplantation: A Multi-Center, Retrospective Cohort Study
Kang He (Renji Hospital, Shanghai Jiao Tong University School of Medicine, China) |
Abstract | |
| 17:20-17:30 |
Immunosuppressive Medication Non-Adherence in Liver Transplant Recipients in VietNam
Anh Nguyen Thi Van (Vietnam) |
Abstract | |
| 17:30-17:40 |
Safety and Efficacy of Tacrolimus Granules in Chinese Pediatric Liver Transplant Recipients: Insights from Two Phase IV Multicenter Studies
Mingxuan Feng (Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China) |
Abstract | |
|
November 15 (Fri) 16:40-17:40 |
Oral Presentation 4 (Kidney/Pancreas)
ENG
|
Room 6F-1 | |
|---|---|---|---|
| Chair(s) |
Sun Cheol Park (The Catholic University of Korea, Korea) Seungyeup Han (Keimyung University, Korea) |
||
| 16:40-16:50 |
Discovering the Mechanism of Tacrolimus Induced Pancreatic Beta Cell Injury by Using Single RNAseq Analysis
Sang Hun Eum (Incheon St. Mary's hospital, The Catholic University of Korea, Korea) |
Abstract | |
| 16:50-17:00 |
The Impact of SARS-CoV-2 Vaccination on the Incidence of Early Allograft Rejection in Kidney Transplant Recipients
Niang-Cheng Lin (Taipei Veterans General Hospital, Taiwan) |
Abstract | |
| 17:00-17:10 |
Triglyceride-Glucose Index and Risk of Cardiovascular Events, Renal Allograft Loss, and New Onset Diabetes After Transplantation in Renal Transplant Recipients
Lee Yuho (CHA Bundang Medical Center, Korea) |
Abstract | |
| 17:10-17:20 |
Successful Kidney Transplantations from Cyanide-Poisoned Donors: the Only Two Documented Cases in Korea
JeeHyun Park (Korea University Anam Hospita, Korea) |
Abstract | |
| 17:20-17:30 |
Protective Effect of Combined Use of Liraglutide and Empagliflozin on Tacrolimus-Induced Diabetes Mellitus and Nephrotoxicity in a Rat Model
Do-Hyun Na (The Catholic University of Korea Seoul St. Mary's Hospital , Korea) |
Abstract | |
| 17:30-17:40 |
De Novo Use of Tacrolimus Granules in Pediatric Kidney Transplant Recipients: Integrated Safety and Efficacy Results from Two Multicenter Open-Label Studies in China
Longshan Liu (The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China) |
Abstract | |
|
November 15 (Fri) 16:40-17:40 |
Oral Presentation 5 (Basic)
ENG
|
Room 5F-2 | |
|---|---|---|---|
| Chair(s) |
Hyun Je Kim (Seoul National University, Korea) Yoshito Yamada (Kyoto University Graduate School of Medicine, Japan) |
||
| 16:40-16:50 |
Molecular Mechanisms of Immune Tolerance for Anti-Host and Anti-Donor T Cells in Mixed Chimeras
Yaxun Huang (Second Xiangya Hospital, Central South University, China) |
Abstract | |
| 16:50-17:00 |
Graft-Infiltrating Regulatory T Cells Contribute Maintenance Transplant Tolerance
Kyohei Kuriyama (Juntendo University Center for Immunotherapy and Diagnosis, Japan) |
Abstract | |
| 17:00-17:10 |
Characterizing the Underlying Mechanisms of Antibody-Mediated Rejection in Kidney Transplantation Using a Multiome Approach
Minji Kang (Seoul National University Graduate School, Korea) |
Abstract | |
| 17:10-17:20 |
GSDMD and Its Concomitant Pyroptosis Are Potential Therapeutic Target in Acute Cardiac Transplantation Rejection
Weihua Gong (Zhejiang University, China) |
Abstract | |
| 17:20-17:30 |
The Autophagy Level of Myocardioblasts Could Significantly Alter the Process of Cardiac Acute Rejection
Weihua Gong (Zhejiang University, China) |
Abstract | |
| 17:30-17:40 |
Exploring the Molecular Pathways of Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease Using Proteomic Analysis
Jin-Myung Kim (Asan Medical Center, Korea) |
Abstract | |
|
November 15 (Fri) 16:40-17:40 |
Oral Presentation 6 (Xenotransplantation)
ENG
|
Room 6F-2 | |
|---|---|---|---|
| Chair(s) |
Junho Chung (Seoul National University, Korea) Eiji Kobayashi (Jikei University, Japan) |
||
| 16:40-16:50 |
World's First Trial Assessing Feasibility and Safety of Genetically-Engineered Pig Red Blood Cell Xenotransfusion in a Brain-Dead Human Subject
Hidetaka Hara (The Second Affiliated Hospital, Hainan Medical University, China) |
Abstract | |
| 16:50-17:00 |
The Results of Partial Thickness Corneal Xenotransplantation to Non-Human Primates Using Multiple Gene-Engineering Pigs.
Ki Cheul Shin (Konkuk University Medical Center, Korea) |
Abstract | |
| 17:00-17:10 |
Immunological and Pathological Outcomes for Immunosuppressant Combinations in Kidney Xenotransplantation Using Multiple, Genetically Modified Pigs
Kyu-Hyun Han (Yonsei University College of Medicine, Korea) |
Abstract | |
| 17:10-17:20 |
Antibodies to Unknown Antigens Other Than Swine Leukocyte Antigens on GTKO/4GalNT2KO Pig Cells Are Associated With Acute Humoral Xenograft Rejection
Songzhe He (The Second Affiliated Hospital of Hainan Medical University, China) |
Abstract | |
| 17:20-17:30 |
Regulatory Macrophages as a Therapeutic Strategy to Mitigate Immune Responses in Xenotransplantation
Phu Chi Vu (Gachon University, Korea) |
Abstract | |
| 17:30-17:40 |
The Status of Genetically Modified Pigs-to-Brain Dead Patients Xenotransplantation in China
Tao Li (The Second Affiliated Hospital of Hainan Medical University, China) |
Abstract | |
|
November 15 (Fri) 16:40-17:40 |
Oral Presentation 7 (Lung)
ENG
|
Room 5F-3 | |
|---|---|---|---|
| Chair(s) |
Seokjin Haam (Ajou University, Korea) Haruhiko Shiiya (Hokkaido University, Japan) |
||
| 16:40-16:50 |
The Use of Extended Criteria Donors Decreases One-Year Survival in High-Risk Lung Recipients: A Review of the Korean Network for Organ Sharing Database
Eunjeong Choi (Pusan National University Yangsan Hospital, Korea) |
Abstract | |
| 16:50-17:00 |
Surgical Treatment of Pulmonary Artery Aneurysm in Pulmonary Arterial Hypertension Using Venoarterial Extracorporeal Membrane Oxygenation: A Case Report
Ruari Lee (Severance Hospital, Republic of Korea; Lung Center of the Philippines, Philippines) |
Abstract | |
| 17:00-17:10 |
Lung Transplantation for Plueroparenchymal Fibroelastosis a Single Center Experience of 7 Cases
HYE MIN KIM (Severance Hospital, Korea) |
Abstract | |
| 17:10-17:20 |
The Impact of Levels of Preoperative Rehabilitation Prior to Lung Transplantation in ECMO Bridged Patients
Ruari Lee (Severance Hospital, Republic of Korea; Lung Center of the Philippines, Philippines) |
Abstract | |
| 17:20-17:30 |
Comparison of Short Stature Versus Non-Short Stature Recipients in Lung Transplantation
Bubse Na (Seoul National University Hospital, Korea) |
Abstract | |
| 17:30-17:40 |
Case Series of Lung Transplantation for Pleuroparenchymal Fibroelastosis: Remodeling of Thoracic Cavity
Ha Eun Kim (Yonsei University College of Medicine, Korea) |
Abstract | |
|
November 15 (Fri) 18:00-20:00 |
Gala Dinner
|
Room 3F-1 | |
|---|---|---|---|
Log in to ATW 2024 website,
navigate to “My Page” > “Registration”, and
click “Certificate of Attendance” to download your confirmation.
Discover the unforgettable moments
of ATW 2024 in our Photo Gallery!
This website is operated by the secretariat (hereafter referred to as ‘SECRETARIAT’ or ‘We’) of the ATW 2024 (hereafter referred to as ‘MEETING’), and this privacy policy applies to this website only.
At atweek.org (hereafter referred to as ‘WEBSITE’), the SECRETARIAT respects its participants and understands that you are concerned about privacy. We are posting this privacy policy to let you know what kind of information we collect, how it is handled, with whom it may be shared, what choices you have regarding the SECRETARIAT’s use of your information, and how you may access some of the data you provide to the SECRETARIAT.
As the SECRETARIAT continues to develop the WEBSITE and take advantage of technologies to improve the services we offer, the privacy policy may change. We therefore encourage you to refer to this policy on an ongoing basis so that you understand the SECRETARIAT’s current privacy policy.
If you have any questions about this policy, please contact our Privacy Protection Manager at atweek@insession.co.kr
What Information Do We Collect? The SECRETARIAT collects various types of information depending upon how you use the WEBSITE:
A cookie is a small piece of information sent by a website, which is saved on your hard disk by your computer's browser. It holds information a site may need to interact with you and personalize your experience. At the WEBSITE, we use two kinds of cookies: session cookies and persistent cookies. Session cookies exist only for as long as your browser remains open. Once you exit your browser, they go away. The SECRETARIAT uses session cookies to maintain information we need to have in order for you to register for the MEETING. For example, the Session ID cookie that we ask your browser to hold retains the ID for My Page. Without the Session ID cookie, you cannot add and modify any information that you input at the time of your sign-up.
Persistent cookies, in contrast, last from visit to visit; they do not go away when you exit your browser. At the WEBSITE, we use persistent cookies to give you a more personalized browse and to help you navigate the WEBSITE more efficiently. The SECRETARIAT will use your information to enhance your site experience. However, you can use the WEBSITE without accepting a persistent cookie. To do so, you should set your browser options to reject persistent cookies. Alternatively, you can set your browser to notify you when you receive a cookie, which gives you the opportunity to decide whether you want to accept it or not. In many instances, the Help button on your browser toolbar will tell you how you can take these steps.
Cookies can be used by a website to recognize you. But that does not necessarily mean any personal information is stored in the cookies. At the WEBSITE, we store no personal information about you in the cookies. Anything you choose to tell us about yourself (such as your address and email address) is stored safely and separately on our secured servers, and you need to provide a password to access it.
The SECRETARIAT also uses cookies to look at how groups, rather than individuals, use the WEBSITE. In our administration page, we can observe which aisles and departments are most heavily trafficked and determine the best method to improve the experience for visitors. On the web, cookies help us develop a similar understanding so that we can continue to improve the arrangement, product offerings, registration and abstract submission at the WEBSITE.
The SECRETARIAT may use your information in a number of ways, including the following:
The information gathered may be shared with the ATW 2024 Organizing Committee and our family associations. We also share the information with third parties, including responsible committees with which we have a relationship. For example:
In most of the above situations, these third parties will receive your information because you will be visiting their websites or using their links and, in doing so, you may provide information directly to them. You therefore should refer to their privacy policies to understand how they handle your information and what kinds of choices you have.
The SECRETARIAT also may share your personal information with outside companies that perform services for the MEETING. For example, we may retain an outside company to manage a database containing certain participants’ information or to create and distribute an email offering. In those situations, the outside party is performing work for the WEBSITE, and the SECRETARIAT includes language in its contracts stating that your information is to be used only to provide the services requested by the SECRETARIAT.
Additionally, the SECRETARIAT may share account or other information when we believe it is necessary to comply with law or to protect the SECRETARIAT’s interests or property. This may include sharing information with other companies, committees, lawyers, credit bureaus, agents or government agencies in connection with issues related to fraud, credit or debt collection.
In the event that some or all of the business assets of the MEETING are sold or transferred, we generally would transfer the corresponding information about the participants of the MEETING.
Finally, the SECRETARIAT may share your personal information with unrelated outside companies so that they can directly promote the services to you if we feel that the companies offer services that we believe may be of interest. We also may provide you with the opportunity to create an account on our website to receive email offers from other companies.
What Choices Do You Have Regarding the Use of Your Information? The SECRETARIAT provides you with a number of choices regarding our handling of your personal information.
If you wish to change your email preferences, please click on the unsubscribe link at the bottom of any SECRETARIAT’s e-mail and describe the request such as “Please do not send me email," or “Keep my email address private."
Note: Once you have submitted your email opt-out request, you should assume that it has been successfully received and your request is being processed. Please allow us 10 business days from when the request is received to complete the removal, as some of our promotions may already have been in process before you submitted your request.
You also may use the address and phone number above to request that we not reveal your personal information to unrelated third parties for marketing purposes. If you choose to write to the SECRETARIAT, please include your name, address, and credit card account number to be used for settlement and state "NO THIRD PARTY SHARING" in your request.
If you are a user who has already signed up for the MEETING, you can update your information in “My Page,” and if you have questions about your status, you may also check them online in “My Page.”
If you would like, you may also an email to the SECRETARIAT.
Questions regarding your charge account may be forwarded to our Credit Customer Service Department.
The SECRETARIAT has put in place various physical, electronic, and managerial procedures to try to safeguard and secure the information we collect online. For example, private account and customer information is located on a secured server behind a firewall; it is not directly connected to the Internet. Encryption is a process by which a message or information is scrambled while it is in transit to the SECRETARIAT. It is based on a key that has two different parts, public and private. The public part of the key is distributed to those with whom you want to communicate. The private part is for the recipient's use only. So long as you use a browser that allows for encryption, when you send personal information to the SECRETARIAT, you use a public key to encrypt your personal information. If your information is intercepted during the transmission, it is scrambled and very difficult to decrypt. Once we receive your encrypted personal information, we use the private part of our key to decode it.
Please note however that while we implement many security measures on this site, 100% security cannot be guaranteed.
Thank you for your visit to the WEBSITE. If you have any questions or comments about this policy, please email the SECRETARIAT (atweek@insession.co.kr).
ATW 2024 will be held in Seoul, from November 14 to November 16, 2024. Your use of atweek.org will always be subject to, at a minimum, the terms and conditions set out in this document. These are referred to as the "Master Terms." In addition, your use of the Website may also be subject to the terms of any legal notice applicable to the Website in addition to the Master Terms. All such terms supplementing these Master Terms are referred to below as "Additional Terms." The Master Terms, together with any Additional Terms, form a binding legal agreement between you and ATW 2024 in relation to your use of the Website. Collectively, this legal agreement is referred to below as the "Terms." If there is any contradiction between the Additional Terms and the Master Terms, then the Additional Terms shall take precedence in relation to the Website to which the Additional Terms apply.
Your access or use of atweek.org in any way signifies that you have read, understand, and agree to be bound by the terms. By accessing or using atweek.org, you also represent that you have the legal authority to accept the Terms on behalf of yourself and any party you represent in connection with your use of the Website. If you do not agree to the Terms, you are not authorized to use the Website.
ATW 2024 may change, remove, add to modify the Terms, and reserves the right to do so in its discretion. In that case, we will post the updated Master Terms or Additional Terms, as relevant, to the Website and indicate the date of revision. We may send a message to your email address, or we may display a notice on the Website indicating that the Terms have changed. All amended Terms take effect immediately. If you do not agree with any modification to the Terms, you may terminate this agreement by ceasing use of the Website. Your continued use of the Website after the revised Terms are effective indicates that you have read, understood, and agreed to those Terms.
ATW 2024 makes the Website available to you on the Terms. You may only use the Website in accordance with these Master Terms and any applicable Additional Terms. In particular but without limitation, you may not use the Website for any purpose that is unlawful or prohibited by these Master Terms, any applicable Additional Terms, or any other conditions or notices that are made available on any Website.
The Website Services are controlled and offered by ATW 2024 in Korea. ATW 2024 makes no representations that the Website is appropriate or available for use in other locations. If you are accessing or using any Website from other jurisdictions, you do so at your own risk and you are responsible for compliance with local laws.
You understand that all material, data, and information, (collectively, "Content") which you may have access to through your use of the Website are the sole responsibility of the person from which such Content originated. This includes assertions that persons may make, expressly or impliedly, about the provenance and ownership of Content that they supply, upload, list and/or link to. You acknowledge that ATW 2024 does not make any representations or warranties about the accuracy, integrity or quality of the Content made available at the instigation of users of the Website. You understand that by using the Website, you may be exposed to Content that is offensive, indecent or objectionable. Under no circumstances is ATW 2024 liable in any way for any Content, including but not limited to: any infringing Content, any errors or omissions in Content, or for any loss or damage of any kind incurred as a result of the use of any Content posted, transmitted to, linked to or otherwise accessible or made available via the Website Services.
Content You Provide.You may only submit Content to the Website. This means that you can only submit Content that you yourself create, that is in the public domain or that you have been expressly granted the right to submit consistent with the Terms. For the avoidance of doubt, Content that infringes the rights of any third party must not be submitted. You represent, warrant, and agree that no Content of any kind submitted, posted or otherwise shared by you on or through any of the Website Services, violates or infringes upon the rights of any third party, including copyright, trademark, privacy, publicity or other personal or proprietary rights, or contains libelous, defamatory or otherwise unlawful material. Further, you represent, warrant, and agree not to submit any personally identifiable information. ATW 2024 may review your submissions and may delete or remove without notice any Content in its sole discretion that ATW 2024 determines violates the Terms or that may be offensive, illegal, or that might violate the rights, harm or threaten the safety of others. ATW 2024 does not endorse or support any Content posted by you. You alone are responsible for creating backup copies and replacing any Content you post on the Website, and you authorize ATW 2024 to make copies of your Content as we deem necessary in order to facilitate the posting of your Content on the Website.
Use of Content on the Website.You represent and warrant to ATW 2024 that you will use any and all Content on our Website in accordance with the applicable license. By using the Website, you agree that you are solely responsible for your use of any and all Content made available thereon. You agree that you must evaluate, and bear all risks associated with, the use of any Content, including any reliance on the provenance, ownership, accuracy, completeness or reliability of such Content. In this regard, you acknowledge that you may not rely on any Content made available on the Website without your own independent evaluation of that Content. ATW 2024 does not guarantee that Content made available on the Website does not infringe the rights of any third party.
By registering for an account on the Website, you agree to abide by all of the terms and conditions of these Master Terms and any applicable Additional Terms. ATW 2024 reserves the right to modify or discontinue the accounts of Registered Users and related Services at any time. ATW 2024 disclaims any and all liability to Registered Users.
SecurityYou agree to (a) provide accurate, current and complete information about you, if and as may be prompted by the registration process on the Website, (b) maintain the security of your password and identification, (c) maintain and promptly update your registration information and any other information you provide, and to keep it accurate and complete to, among other things, allow us to contact you, and (d) be fully responsible for all use of your account and for any actions that take place using your account. You may not set up an account or membership on behalf of another individual or entity.
Termination and Inactivation of User Accounts.Your participation as a Registered User terminates automatically upon your breach of any of these Master Terms or applicable Additional Terms. In addition, ATW 2024 may, at any time: (a) modify, suspend or terminate the operation of or access to your user account for any reason; (b) modify or change the Website and Services and any applicable Terms and policies governing your user account and related Website Services for any reason; and (c) interrupt user accounts and related Website Services for any reason, all as ATW 2024 deems appropriate in its discretion. Your access to your account and use of the Website may be terminated by you or by ATW 2024 at any time and for any reason whatsoever without notice. In addition, ATW 2024 reserves the right to delete and purge any account and all Content associated therewith following any prolonged period of inactivity, all as may be determined by ATW 2024 in its complete discretion.
To the fullest extent permitted by the applicable law, ATW 2024 offers the Website and Services as-is and makes no representations or warranties of any kind concerning the Website Services. ATW 2024 does not warrant that the functions or content contained on the Website will be uninterrupted or error-free, that defects will be corrected, or that ATW 2024's servers are free of viruses or other harmful components. ATW 2024 does not warrant or make any representation regarding the use or the result of use of the Content in terms of accuracy, reliability, or otherwise.
ATW 2024 shall not be responsible or liable whatsoever in any manner for any Content posted on the Website for your use of the Website Services.
ATW 2024 is committed to handling responsibly the information and data we collect through our Website and agrees to use your personal information in accordance with the Privacy Policy. The Privacy Policy is hereby incorporated by reference into these Master Terms.
ATW 2024 respects the intellectual property rights of others, and we prohibit users of our Website from submitting, uploading, posting or otherwise transmitting any materials that violate another person's intellectual property rights.
These Master Terms and any Additional Terms will continue to apply until terminated by either you or ATW 2024 as set out below. Your right to access and use the Website terminates automatically upon your breach of any of these Master Terms or Additional Terms that may apply to any of the Website Services. ATW 2024 may, at any time: (a) modify, suspend or terminate the operation of or access to any of the Website Services, or any portion of the Website Services, for any reason; (b) modify or change the Website Services, or any portion of the Website Services, and any Master Terms, Additional Terms, and other policies governing the use of the Website Services, for any reason; (c) interrupt the operation of the Website Services, or any portion of the Website Services, for any reason, all as ATW 2024 deems appropriate in its sole discretion. Your access to, and use of, the Website Services may be terminated by you or by ATW 2024 at any time and for any reason. ATW 2024 will use reasonable efforts to notify you in advance about any material modification, suspension or termination by ATW 2024 that is not caused by your breach of the Terms.
This Master Term constitutes the entire agreement between you and ATW 2024 relating to this subject matter and supersedes all prior, contemporaneous, and future communications between you and ATW 2024.
These Terms of Use are Effective as of June 4, 2024
